{"id":"https://openalex.org/W2903487102","doi":"https://doi.org/10.1182/blood-2018-99-115678","title":"Predicting Response to Dasatinib Using a Computational Model and Its Validation: A Beat AML Project Study","display_name":"Predicting Response to Dasatinib Using a Computational Model and Its Validation: A Beat AML Project Study","publication_year":2018,"publication_date":"2018-11-29","ids":{"openalex":"https://openalex.org/W2903487102","doi":"https://doi.org/10.1182/blood-2018-99-115678","mag":"2903487102"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2018-99-115678","doi":"https://doi.org/10.1182/blood-2018-99-115678","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-115678","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5134831711","display_name":"Jeffrey W Tyner","orcid":"https://orcid.org/0000-0002-2133-0960","observed_orcids":["https://orcid.org/0000-0002-2133-0960"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey W. Tyner","raw_affiliation_strings":["Knight Cancer Institute, Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Knight Cancer Institute, Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University, Portland, OR","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125591963","display_name":"Brian J. Druker","orcid":"https://orcid.org/0000-0001-8331-8206","observed_orcids":["https://orcid.org/0000-0001-8331-8206"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian J. Druker","raw_affiliation_strings":["Knight Cancer Institute, Oregon Health & Science University, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Knight Cancer Institute, Oregon Health & Science University, Portland, OR","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014545118","display_name":"Cristina E. Tognon","orcid":"https://orcid.org/0000-0002-4872-3078","observed_orcids":["https://orcid.org/0000-0002-4872-3078"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Cristina E. Tognon","raw_affiliation_strings":["Knight Cancer Institute, Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Knight Cancer Institute, Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075070858","display_name":"Stephen E. Kurtz","orcid":"https://orcid.org/0000-0003-4762-389X","observed_orcids":["https://orcid.org/0000-0003-4762-389X"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Stephen E Kurtz","raw_affiliation_strings":["Knight Cancer Institute, Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Knight Cancer Institute, Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065927929","display_name":"Leylah M. Drusbosky","orcid":"https://orcid.org/0000-0002-9401-4600","observed_orcids":["https://orcid.org/0000-0002-9401-4600"]},"institutions":[{"id":"https://openalex.org/I2800717037","display_name":"University of Florida Health","ror":"https://ror.org/04tk2gy88","country_code":"US","type":"education","lineage":["https://openalex.org/I2800717037","https://openalex.org/I33213144"]},{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leylah M. Drusbosky","raw_affiliation_strings":["Department of Medicine/Division of Hematology Oncology, University of Florida, Gainesville, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine/Division of Hematology Oncology, University of Florida, Gainesville, FL","institution_ids":["https://openalex.org/I2800717037","https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112537034","display_name":"Diwyanshu Sahu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097570","display_name":"Cellworks Research (India)","ror":"https://ror.org/00wgjgc44","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210097570"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Diwyanshu Sahu","raw_affiliation_strings":["Cellworks Research India Private Limited, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellworks Research India Private Limited, Bangalore, India","institution_ids":["https://openalex.org/I4210097570"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101543600","display_name":"Robinson Vidva","orcid":"https://orcid.org/0000-0002-2604-5448","observed_orcids":["https://orcid.org/0000-0002-2604-5448"]},"institutions":[{"id":"https://openalex.org/I4210097570","display_name":"Cellworks Research (India)","ror":"https://ror.org/00wgjgc44","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210097570"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Robinson Vidva","raw_affiliation_strings":["Cellworks Research India Private Limited, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellworks Research India Private Limited, Bangalore, India","institution_ids":["https://openalex.org/I4210097570"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102152144","display_name":"Shweta Kapoor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097570","display_name":"Cellworks Research (India)","ror":"https://ror.org/00wgjgc44","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210097570"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Shweta Kapoor","raw_affiliation_strings":["Cellworks Research India Private Limited, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellworks Research India Private Limited, Bangalore, India","institution_ids":["https://openalex.org/I4210097570"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108727331","display_name":"Humera Azam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097570","display_name":"Cellworks Research (India)","ror":"https://ror.org/00wgjgc44","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210097570"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Humera Azam","raw_affiliation_strings":["Cellworks Research India Private Limited, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellworks Research India Private Limited, Bangalore, India","institution_ids":["https://openalex.org/I4210097570"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105423593","display_name":"Rajeev Kumar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097570","display_name":"Cellworks Research (India)","ror":"https://ror.org/00wgjgc44","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210097570"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Rajeev Kumar","raw_affiliation_strings":["Cellworks Research India Private Limited, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellworks Research India Private Limited, Bangalore, India","institution_ids":["https://openalex.org/I4210097570"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081214838","display_name":"Padmagiri G Chickdipatti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097570","display_name":"Cellworks Research (India)","ror":"https://ror.org/00wgjgc44","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210097570"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Padmagiri G Chickdipatti","raw_affiliation_strings":["Cellworks Research India Private Limited, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellworks Research India Private Limited, Bangalore, India","institution_ids":["https://openalex.org/I4210097570"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018670163","display_name":"Nithya T Raveendaran","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097570","display_name":"Cellworks Research (India)","ror":"https://ror.org/00wgjgc44","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210097570"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Nithya T Raveendaran","raw_affiliation_strings":["Cellworks Research India Private Limited, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellworks Research India Private Limited, Bangalore, India","institution_ids":["https://openalex.org/I4210097570"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008525563","display_name":"Reshma P Gopi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097570","display_name":"Cellworks Research (India)","ror":"https://ror.org/00wgjgc44","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210097570"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Reshma P Gopi","raw_affiliation_strings":["Cellworks Research India Private Limited, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellworks Research India Private Limited, Bangalore, India","institution_ids":["https://openalex.org/I4210097570"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086399567","display_name":"Taher Abbasi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Taher Abbasi","raw_affiliation_strings":["Cell Works Group Inc., San Jose, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cell Works Group Inc., San Jose, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108215045","display_name":"Shireen Vali","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Shireen Vali","raw_affiliation_strings":["Cell Works Group Inc., San Jose, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cell Works Group Inc., San Jose, CA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042492175","display_name":"Christopher Ramin Cogle","orcid":"https://orcid.org/0000-0001-5422-6863","observed_orcids":["https://orcid.org/0000-0001-5422-6863"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher R. Cogle","raw_affiliation_strings":["University of Florida, Gainesville, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Florida, Gainesville, FL","institution_ids":["https://openalex.org/I33213144"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5008525563","https://openalex.org/A5014545118","https://openalex.org/A5075070858","https://openalex.org/A5086399567","https://openalex.org/A5102152144","https://openalex.org/A5108215045","https://openalex.org/A5108727331","https://openalex.org/A5112537034"],"corresponding_institution_ids":["https://openalex.org/I165690674","https://openalex.org/I4210097570","https://openalex.org/I4390039369"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"132","issue":"Supplement 1","first_page":"1541","last_page":"1541"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9629999995231628},{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/receptor-tyrosine-kinase-mutations","display_name":"receptor tyrosine kinase mutations","score":0.8759999871253967},{"id":"https://openalex.org/keywords/flt3-itd-mutation","display_name":"FLT3-ITD","score":0.8820000290870667},{"id":"https://openalex.org/keywords/flt3-tkd","display_name":"FLT3-TKD","score":0.9549999833106995},{"id":"https://openalex.org/keywords/kit","display_name":"KIT","score":0.8479999899864197},{"id":"https://openalex.org/keywords/pdgfr","display_name":"PDGFR","score":0.9819999933242798},{"id":"https://openalex.org/keywords/ex-vivo-drug-sensitivity-testing","display_name":"ex vivo drug sensitivity testing","score":0.8389999866485596},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7099999785423279},{"id":"https://openalex.org/keywords/risk-of-relapse","display_name":"relapse risk","score":0.6809999942779541},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.4860000014305115}],"concepts":[{"id":"https://openalex.org/C2779536868","wikidata":"https://www.wikidata.org/wiki/Q419940","display_name":"Dasatinib","level":4,"score":0.9350935220718384},{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.6555935740470886},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.5506547689437866},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5021538734436035},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49306604266166687},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.4823000431060791},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.4399442672729492},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.41348618268966675},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.387138307094574},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.3427891731262207},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3308221995830536},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.31855472922325134},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.22526979446411133},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.2065182626247406},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.10517707467079163}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2018-99-115678","doi":"https://doi.org/10.1182/blood-2018-99-115678","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-115678","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2910027809","https://openalex.org/W2910297739","https://openalex.org/W4310114272","https://openalex.org/W2971848247","https://openalex.org/W3022331569","https://openalex.org/W2611915447","https://openalex.org/W2983808298","https://openalex.org/W2913014520","https://openalex.org/W4405043837","https://openalex.org/W2552824830"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"New":[2],"prognostic":[3],"factors":[4],"have":[5],"been":[6],"recently":[7],"identified":[8],"in":[9,42,59,212,240,253,276,293,302,335,342,354,375,386,396,409],"AML":[10,43,60,72,89,162,200,207,243,252,255,376],"patient":[11,61],"population":[12],"that":[13,26,129,321],"include":[14],"frequent":[15],"mutations":[16,211,327,341,385,404],"of":[17,32,142,183,188,279,288,299,323,340,356,399,459,479,508,520,535,550,575,597,609,623,637,653,723],"receptor":[18],"tyrosine":[19],"kinases":[20],"(RTK)":[21],"including":[22],"KIT,":[23],"PDGFR,":[24,217],"FLT3,":[25],"are":[27,94],"associated":[28],"with":[29,63,150,257,282,350,377],"higher":[30],"risk":[31],"relapse.":[33],"Thus,":[34],"targeting":[35],"RTKs":[36],"could":[37],"improve":[38],"the":[39,56,76,198,232,273,303,357],"therapeutic":[40],"outcome":[41],"patients.":[44,90],"Aim:":[45],"To":[46],"create":[47],"a":[48,121,160,179],"digital":[49],"drug":[50,66,106,148,157,189,373],"model":[51],"for":[52,231,332,393],"dasatinib":[53,151,194,267,317,372,394],"and":[54,84,102,132,144,171,245,261,297,310,345,402],"validate":[55],"predicted":[57,247],"response":[58,174,190,336,374,395,411],"samples":[62,93],"ex":[64,104,201,237,318,381],"vivo":[65,105,202,238,266,382],"sensitivity":[67,107],"testing.":[68,203],"Methods:":[69],"The":[70],"Beat":[71,199],"project":[73],"(supported":[74],"by":[75,96,154,248],"Leukemia":[77,614],"&":[78,221,470,486,490,495,559,615],"Lymphoma":[79,616],"Society)":[80],"collects":[81],"clinical":[82],"data":[83],"bone":[85],"marrow":[86,92],"specimens":[87],"from":[88,197],"Bone":[91],"analyzed":[95],"conventional":[97],"cytogenetics,":[98],"whole-exome":[99],"sequencing,":[100],"RNA-seq,":[101],"an":[103,213,456,476,505,517,532,547,572,594,606,620,634,650],"assay.":[108],"For":[109],"50":[110],"randomly":[111],"chosen":[112],"patients,":[113],"every":[114],"available":[115],"genomic":[116,290],"abnormality":[117],"was":[118,175,246],"inputted":[119],"into":[120],"computational":[122],"biology":[123,365],"program":[124],"(Cell":[125],"Works":[126,709,714],"Group":[127,710,715],"Inc.)":[128],"uses":[130],"PubMed":[131],"other":[133],"online":[134],"resources":[135],"to":[136,193,250,272,286,316,337,348,370,380,412],"generate":[137],"patient-specific":[138],"protein":[139],"network":[140],"maps":[141],"activated":[143],"inactivated":[145],"pathways.":[146],"Digital":[147],"simulations":[149],"were":[152,191,227,269,314],"conducted":[153],"quantitatively":[155],"measuring":[156],"effect":[158],"on":[159,178,455,475,504,516,531,546,571,593,605,619,633,649],"composite":[161],"disease":[163],"inhibition":[164],"score":[165],"(DIS)":[166],"(i.e.,":[167],"cell":[168],"proliferation,":[169],"viability,":[170],"apoptosis).":[172],"Drug":[173],"determined":[176],"based":[177],"DIS":[180],"threshold":[181],"reduction":[182],">":[184],"65%.":[185],"Computational":[186,364],"predictions":[187],"compared":[192],"IC50":[195],"values":[196],"Results:":[204],"23/50":[205],"(46%)":[206],"patients":[208,244,256,280,309,313],"had":[209],"somatic":[210,324],"RTK":[214,233,325,387],"gene":[215,326],"(KIT,":[216],"FLT3":[218],"(ITD":[219],"(n=15)":[220],"TKD":[222],"(n=4)),":[223],"while":[224],"27/50":[225],"(54%)":[226],"wild":[228],"type":[229],"(WT)":[230],"genes.":[234],"Dasatinib":[235],"showed":[236],"cytotoxicity":[239],"9/50":[241,254],"(18%)":[242],"CBM":[249,274],"remit":[251],"4":[258],"true":[259],"responders":[260],"5":[262],"false":[263],"positive.":[264],"Ex":[265],"responses":[268],"correctly":[270],"matched":[271],"prediction":[275],"40/50":[277],"(80%)":[278],"(Table1),":[281],"10":[283,355],"mismatches":[284],"due":[285],"lack":[287],"sufficient":[289],"information":[291],"resulting":[292],"profile":[294],"creation":[295],"issues":[296],"absence":[298],"sensitive":[300,315],"loops":[301],"profile.":[304],"Only":[305],"4/23":[306],"(17%)":[307],"RTK-mutant":[308],"5/27(19%)":[311],"RTK-WT":[312],"vivo,":[319],"indicating":[320],"presence":[322],"may":[328,389,405],"not":[329,390],"be":[330,368,391,406],"essential":[331],"leukemia":[333],"regression":[334],"dasatinib.":[338,413],"Co-occurrence":[339,398],"NRAS,":[343,400],"KRAS":[344,401],"NF1":[346],"seemed":[347],"associate":[349],"resistance":[351],"as":[352],"seen":[353],"14":[358],"profiles":[359],"harboring":[360],"these":[361],"mutations.":[362],"Conclusion:":[363],"modeling":[366],"can":[367],"used":[369],"simulate":[371],"high":[378],"accuracy":[379],"chemosensitivity.":[383],"DNA":[384],"genes":[388],"required":[392],"AML.":[397],"NF1gene":[403],"important":[407],"co-factors":[408],"modulating":[410],"Disclosures":[414],"Tyner:":[415],"Leap":[416],"Oncology:":[417],"Equity":[418,501,543,568],"Ownership;":[419],"Syros:":[420],"Research":[421,425,428,431,434,437,440,443,446,449,466,527,581,586,588,628,661,667,673,679,685,691,697,703],"Funding;":[422,426,429,432,435,438,441,444,447,467,528,582,589,629],"Seattle":[423],"Genetics:":[424],"Janssen:":[427],"Incyte:":[430],"Gilead:":[433],"Genentech:":[436],"AstraZeneca:":[439],"Aptose:":[442],"Takeda:":[445],"Agios:":[448],"Funding.":[450],"Druker:Third":[451],"Coast":[452],"Therapeutics:":[453,541,643],"Membership":[454,474,503,515,530,545,570,592,604,618,632,648],"entity's":[457,477,506,518,533,548,573,595,607,621,635,651],"Board":[458,478,507,519,534,549,574,596,608,622,636,652],"Directors":[460,480,509,521,536,551,576,598,610,624,638,654],"or":[461,481,510,522,537,552,577,599,611,625,639,655],"advisory":[462,482,511,523,538,553,578,600,612,626,640,656],"committees;":[463,483,512,524,539,554,579,601,613,641,657],"Novartis":[464],"Pharmaceuticals:":[465],"Millipore:":[468],"Patents":[469,489,494,558],"Royalties;":[471,491,496,560],"Vivid":[472],"Biosciences:":[473],"Oregon":[484],"Health":[485],"Science":[487],"University:":[488],"McGraw":[492],"Hill:":[493],"Celgene:":[497],"Consultancy;":[498,564,644],"MolecularMD:":[499],"Consultancy,":[500,514,542,567,603,631,647],"Ownership,":[502,544,569],"GRAIL:":[513],"Bristol-Meyers":[525],"Squibb:":[526],"Amgen:":[529],"Aptose":[540],"Henry":[555],"Stewart":[556],"Talks:":[557],"Patient":[561],"True":[562],"Talk:":[563],"Blueprint":[565],"Medicines:":[566],"ARIAD:":[580],"Fred":[583],"Hutchinson":[584],"Cancer":[585],"Center:":[587],"Beta":[590],"Cat:":[591],"Cepheid:":[602],"Society:":[617],"committees,":[627],"ALLCRON:":[630],"Aileron":[642],"Gilead":[645],"Sciences:":[646],"Monojul:":[658],"Consultancy.":[659],"Sahu:Cellworks":[660],"India":[662,668,674,680,686,692,698,704],"Private":[663,669,675,681,687,693,699,705],"Limited:":[664,670,676,682,688,694,700,706],"Employment.":[665,671,677,683,689,695,701,707,712,717],"Vidva:Cellworks":[666],"Kapoor:Cellworks":[672],"Azam:Cellworks":[678],"Kumar:Cellworks":[684],"Chickdipatti:Cellworks":[690],"Raveendaran:Cellworks":[696],"Gopi:Cellworks":[702],"Abbasi:Cell":[708],"Inc.:":[711,716],"Vali:Cell":[713],"Cogle:Celgene:":[718],"Other:":[719],"Steering":[720],"Committee":[721],"Member":[722],"Connect":[724],"MDS/AML":[725],"Registry.":[726]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2018-12-11T00:00:00"}